<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 14 cases of inflammatory polyneuropathy associated with arboviruses, nine were treated with immunoglobulin. Of the 14 cases with inflammatory polyneuropathy and arboviruses, Zika virus infection was confirmed by reverse transcriptase polymerase chain reaction in one (6.7%) patient; one patient had chikungunya virus confirmed by serology and one patient was positive for dengue virus by laboratory exams. The other 11 (78.6%) patients were diagnosed with arbovirus infection based on clinical symptoms. Of the 14 patients, 8 (57.1%) presented with cutaneous rash, 7 (50.0%) with fever, and 3 (21.4%) conjunctivitis (TableÂ 
 <xref rid="ijgo13050-tbl-0002" ref-type="table">2</xref>). A total of 9 (64.3%) of these 14 patients were treated with intravenous immunoglobulin. No patient was treated with plasma exchange. Five (55.6%) of the nine treated with intravenous immunoglobulin were transferred to other hospitals because the treatment was not available at the first hospital to which they were admitted. As of 2018, 12 (85.7%) of the 14 had no motor deficits, one still had facial paralysis, and one remained quadriplegic.
</p>
